Don't want ads? Subscribe or login now.

Teva Wins Pause Of Order Ousting Patents From Orange Book

By Carla Baranauckas · June 13, 2024, 6:04 PM EDT

A New Jersey federal judge ordered on Thursday a 30-day stay of his Monday ruling that a handful of patents covering Teva-brand asthma inhalers were improperly listed in the federal Orange...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D LLC et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al

Case Number

2:23-cv-20964

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

October 06, 2023

Recent Articles By Carla

November 03, 2025
NJ Justices Unsure Charity Immunity Applies To Clinic
October 24, 2025
3rd Circ. Revives Nonprofit's Bias Suit Over Permit Denial
October 23, 2025
Ex-Exec Accused Of Stealing IVF Co.'s Trade Secrets
October 17, 2025
Animal Medication Co. Mostly Escapes Dog Arthritis Drug Suit
October 10, 2025
Ex-Temple Worker Can Sue Under ADA, Not As Whistleblower
October 06, 2025
Justices Skip Fight Over NJ Healthcare Worker Vax Mandate
October 02, 2025
Mass. Court Denies States' Bid To Block ACA Subsidy Cuts
September 30, 2025
3rd Circ. Parses 'Could' And 'Would' In Lipitor Lawsuit
September 29, 2025
TikTok Can't Use Section 230 To End NJ AG's Harm Suit
September 18, 2025
NJ City Makes 3rd Escape From Pot Co.'s Zoning Suit